Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027947 (
neutropenia
)
17,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Congenital neutropenia comprises a variety of genetically heterogeneous phenotypic traits. Molecular elucidation of the underlying genetic defects has yielded important insights into the physiology of neutrophil differentiation and function. Non-syndromic variants of congenital
neutropenia
are caused by mutations in ELA2, HAX1, GFI1, or WAS. Syndromic variants of congenital
neutropenia
may be due to mutations in genes controlling glucose metabolism (SLC37A4, G6PC3) or lysosomal function (LYST, RAB27A,
ROBLD3
/p14, AP3B1, VPS13B). Furthermore, defects in genes encoding ribosomal proteins (SBDS, RMRP) and mitochondrial proteins (AK2, TAZ) are associated with congenital
neutropenia
syndromes. Despite remarkable progress in the field, many patients with congenital
neutropenia
cannot yet definitively be classified by genetic terms. This review addresses diagnostic and therapeutic aspects of congenital
neutropenia
and covers recent molecular and pathophysiological insights of selected congenital
neutropenia
syndromes.
...
PMID:Congenital neutropenia. 2000 20